Clinical Trials

A Phase I clinical trial is currently underway at MD Anderson Cancer Center testing the company’s oncolytic product, Delta24-RGD, for the treatment of malignant gliomas.

New Patients Call:

800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

For information pertaining to recruitment and qualifications for the trial please visit www.clinicaltrial.gov. The study number is NCT00805376.